SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Credit Suisse Maintains Outperform on PTC Therapeutics, Raises Price Target to $58

Credit Suisse maintains PTC Therapeutics (NASDAQ:PTCT) with a Outperform and raises the price target from $54 to $58.

Benzinga · -

Credit Suisse maintains PTC Therapeutics (NASDAQ:PTCT) with a Outperform and raises the price target from $54 to $58.